CTT PHARMACEUTICAL HOLDINGS, INC. - FORM 10-K/A - EX-23.1 - CONSENT OF AUDITORS

Attached files

file	filename
10-K/A - AMENDED ANNUAL REPORT - CTT PHARMACEUTICAL HOLDINGS, INC.	mdst_10k.htm
EX-31.2 - OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT - CTT PHARMACEUTICAL HOLDINGS, INC.	mdst_ex31z2.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED - CTT PHARMACEUTICAL HOLDINGS, INC.	mdst_ex32z2.htm
EX-31.1 - OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT - CTT PHARMACEUTICAL HOLDINGS, INC.	mdst_ex31z1.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED - CTT PHARMACEUTICAL HOLDINGS, INC.	mdst_ex32z1.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our Auditors’ report, dated October 1, 2015 accompanying the audited consolidated financial statements for the years ended December 31, 2014 and 2013 of CTT Pharmaceutical Holdings, Inc. (formerly, “Mindesta, Inc.”) We hereby consent to the incorporation of such report in this form 10-K/A CTT Pharmaceutical Holdings, Inc. (formerly, “Mindesta, Inc.”) for the year ended December 31, 2014.

[mdst_ex23z1003.jpg]


Vancouver, Canada	MNP LLP, Chartered Accountants

October 8, 2015

Attached files

Stock widget

Investing forum

CTT PHARMACEUTICAL HOLDINGS, INC. Reports